Search Results for: GWPH

FDA Expands GW Pharma’s Epidiolex Label

FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex – Age-range for all EPIDIOLEX indications expanded to include patients one year of age and...
- August 3rd, 2020 at 7:35 am

Cannabis Earnings Season Revs Into High Gear

The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5 million per...
- May 18th, 2020 at 10:58 am

GW Pharma Generates $109 Million Revenue in Q4

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2019 Financial Results and Operational Progress Total revenue of $109.1 million for the fourth quarter and $311.3 million for the full...
- February 25th, 2020 at 4:24 pm

Cannabis Earnings Season Kickoff Reveals Mixed Trends

The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5 million per...
- November 17th, 2019 at 2:06 pm

Cannabis Stocks Retreat in May

After a 57.4% rebound in Q1 followed by a narrow decline in April, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up substantial ground in May, declining...
- June 3rd, 2019 at 8:39 am